Evogliptin prevents ceramide-induced pyroptosis during calcification via modulation of NLRP3/GSDM-D mediated pathway in Vascular Smooth Muscle Cells
PLOS One · 2025
DOI: 10.1371/journal.pone.0337200 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Razia Rashid Rahil und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, School of Life Sciences, Central University of Kashmir, Ganderbal, India. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Pyroptosis, Muscle, Smooth, Vascular, Ceramides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Biotechnology, New Delhi, India, for providing Ramalingaswami fellowship, Ongoing Research Funding Program.
Abstract (Originalsprache)
Evogliptin, an anti-diabetic drug had positive impact on various cardiovascular events including inflammation and vascular calcification (VC), an active process driven by vascular smooth muscle cell (VSMC) phenotypic transition. Sphingolipids such as ceramide (CER) mediates inflammation and VC in the vascular tissue. We investigated whether evogliptin ameliorate phenotypic transition and pyroptosis in VSMCs as underlying cause of VC. In cultured VSMCs, isolated from the aorta of (C57/BL6) mouse, we observed more severe calcification with prior treatment of CER in P i -treated VSMCs as detected by Alizarin Red Staining. Prior CER- stimulation led to a marked upregulation of osteogenic markers such as RUNX2, OPN, BMP2 and decreased contractile markers SM22-α and α- SMA in P i -treated VSMCs as compared to control cells. In addition, increased expression of pyroptotic markers such as NLRP3, GSDM-D, IL-1 β , IL-18, and LDH release was observed with prior treatment of CER in P i -treated VSMCs as compared to control cells. Furthermore, MCC950 (NLRP3 inhibitor), disulfiram (GSDM-D inhibitor) and evogliptin significantly downregulated osteogenic and pyroptotic markers including LDH release in both P i ‐induced only and CER + P i -treated VSMCs. Moreover, GW4869 (SMase inhibitor) and evogliptin significantly reduced SMase activity in sphingomyelin (SM)-induced VSMCs as compared to both P i and SM only-treated groups. Also, the cleavage efficiency of GSDM-D was high in P i and CER + P i groups which was reduced with prior treatment of evogliptin. Hence, our data demonstrate that evogliptin alleviates VC by blocking phenotypic transition and associated pyroptosis via modulation of NLRP3/GSDM-D mediated pathway in CER-induced VSMCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, School of Life Sciences, Central University of Kashmir, Ganderbal, India.
- Koch Institute for Integrative Cancer Research at MIT, Cambridge, Massachusetts, United States of America.
- Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
ORCID-Profile: Salman Shamas, Sheikh Fayaz Ahmad, Sabry Mohamed Attia, Owais Mohmad Bhat
Förderung
- Department of Biotechnology, New Delhi, India, for providing Ramalingaswami fellowship
- Ongoing Research Funding Program
Zitieren
APA
Rahil, R. R., Shamas, S., Wani, N. A., Nanda, N., Ahmad, S. F., Attia, S. M., Hamid, A., Zargar, M. A., & Bhat, O. M. (2025). Evogliptin prevents ceramide-induced pyroptosis during calcification via modulation of NLRP3/GSDM-D mediated pathway in Vascular Smooth Muscle Cells. PLOS One. https://doi.org/10.1371/journal.pone.0337200
Vancouver
Rahil RR, Shamas S, Wani NA, Nanda N, Ahmad SF, Attia SM, et al. Evogliptin prevents ceramide-induced pyroptosis during calcification via modulation of NLRP3/GSDM-D mediated pathway in Vascular Smooth Muscle Cells. PLOS One. 2025. doi:10.1371/journal.pone.0337200
BibTeX
@article{Rahil2025,
author = {Rahil, Razia Rashid and Shamas, Salman and Wani, Nissar Ahmad and Nanda, Neha and Ahmad, Sheikh Fayaz and Attia, Sabry Mohamed and Hamid, Abid and Zargar, Mohammad Afzal and Bhat, Owais Mohmad},
title = {Evogliptin prevents ceramide-induced pyroptosis during calcification via modulation of NLRP3/GSDM-D mediated pathway in Vascular Smooth Muscle Cells},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0337200}
}
EUVIMED